InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-18.1%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by McMahon Rebecca E, Présidente de la R&D. Officer active across 1 company, notably Sanara MedTech Inc.. In total, 5 reports have been logged. Activity tracked since 24 August 2021. The latest transaction was disclosed on 17 March 2023 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations5 total
201 shares@ US$41.50100.0% of flowCommon StockSEC:0001493152-23-008368:0
2,410 shares0Common StockSEC:0001493152-23-006861:0
2,047 shares0Common StockSEC:0001493152-22-006536:0
5,339 shares0Common StockSEC:0001654954-21-009470
5,339 shares0Common StockSEC:0001654954-21-009470:0
5 of 5 declarations
About McMahon Rebecca E
Rebecca E. McMahon is the President of R&D at Sanara MedTech Inc. She leads the company's research and development efforts, focusing on innovation in medical technologies. Her leadership is essential for the development of new products and solutions.
